---
title: "HBC will pay back taxes, which is expected to impact the annual net profit attributable to the parent company by 71.474 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/256872121.md"
description: "HBC announced that the company needs to pay an additional corporate income tax and late fees totaling CNY 71.474 million for the 2023 fiscal year, which has been fully paid as of the announcement date. This matter does not involve administrative penalties and is expected to impact the net profit attributable to shareholders of the listed company by CNY 71.474 million for the 2025 fiscal year, with the final amount subject to the audited financial statements for 2025"
datetime: "2025-09-11T08:30:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/256872121.md)
  - [en](https://longbridge.com/en/news/256872121.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/256872121.md)
---

# HBC will pay back taxes, which is expected to impact the annual net profit attributable to the parent company by 71.474 million yuan

According to the announcement from HBC (603077.SH), after self-examination, the company needs to pay a total of RMB 71.474 million in corporate income tax and late fees for the period from January 1, 2023, to December 31, 2023. As of the date of this announcement, the company has completed the payment of the aforementioned taxes and late fees, and this matter does not involve administrative penalties.

The payment of the above taxes and late fees will be included in the profit and loss for the year 2025, and it is expected to affect the net profit attributable to shareholders of the listed company by RMB 71.474 million for the year 2025, subject to the final audited financial statements for 2025

### Related Stocks

- [603077.CN](https://longbridge.com/en/quote/603077.CN.md)

## Related News & Research

- [07:00 ETPolice Praxis Examines the Gap Between Documented Police Training and Institutional Function](https://longbridge.com/en/news/287052681.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [HSA warns public against consuming herbal remedy containing potent steroid](https://longbridge.com/en/news/287022845.md)
- [Microbiotica reports positive results for MB097 in advanced melanoma](https://longbridge.com/en/news/286740265.md)
- [08:59 ETPurina Institute Drives the Conversation on Microbiome Innovation in Veterinary Medicine](https://longbridge.com/en/news/286917434.md)